Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 6/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4762004 | 0.98 | CES2 (0.50) | CES2EPHX1TSHRNAAAPLA2G2C | |
| SCHEMBL18525732 | 0.98 | CES2 (0.50) | CES2EPHX1TSHRNAAAPLA2G2C | |
| SCHEMBL4855767 | 0.93 | — | — | |
| SCHEMBL840550 | 0.83 | — | — | |
| SCHEMBL14211695 | 0.83 | CNR2 (0.59) | TSHRALDH1A1CNR2TRPV1CNR1 | |
| SCHEMBL252825 | 0.82 | EPHX1 (0.45) | CES2EPHX1TSHRNAAACNR2 | |
| SCHEMBL1756788 | 0.82 | EPHX1 (0.45) | CES2EPHX1TSHRNAAACNR2 | |
| SCHEMBL8516233 | 0.80 | EPHX1 (0.48) | CES2EPHX1TSHRNAAAALDH1A1 | |
| SCHEMBL11670372 | 0.80 | EPHX1 (0.48) | CES2EPHX1TSHRNAAACNR2 | |
| SCHEMBL21724593 | 0.80 | EPHX1 (0.48) | CES2EPHX1TSHRNAAACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080193884-A1 | Image Forming Method | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-08-14 | — | — | US | disclosed |
| US-7355074-B2 | Compounds having aromatic rings and side-chain amide-functionality and a method for transporting monovalent anions across biological membranes using the same | THE UNIVERSITY OF MARYLAND (US) | 2008-04-08 | — | — | US | disclosed |
| EP-1906235-A1 | METHOD FOR IMAGE FORMATION | Konica Minolta Medical & Graphic, Inc. (JP) | 2008-04-02 | — | — | EP | disclosed |
| EP-1571491-B1 | Photothermographic material and method of forming images | FUJIFILM CORP (JP) | 2007-09-12 | — | — | EP | disclosed |
| US-7267934-B2 | Method of forming an image | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-11 | — | — | US | disclosed |
| US-7208264-B2 | Photothermographic material and method of forming images | FUJIFILM CORPORATION (JP) | 2007-04-24 | — | — | US | disclosed |
| US-20060014111-A1 | Method of forming an image | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2006-01-19 | — | — | US | disclosed |
| US-20050202353-A1 | Photothermographic material and method of forming images | FUJI PHOTO FILM CO., LTD | 2005-09-15 | — | — | US | disclosed |
| EP-1571491-A1 | Photothermographic material and method of forming images | FUJI PHOTO FILM CO., LTD. (JP) | 2005-09-07 | — | — | EP | disclosed |
| US-20050009921-A1 | Compounds having aromatic rings and side-chain amide-functionality and a method for transporting monovalent anions across biological membranes using the same | MARYLAND, UNIVERSITY OF | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009921-A1 | Compounds having aromatic rings and side-chain amide-functionality and a method for transporting monovalent anions across biological membranes using the same | SLC26A3, SLC22A8, SLC43A1 | CES2 1624/4885EPHX1 2121/4885TSHR 2124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.